CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In order to determine the potential role of the AHR signaling pathway in CML stem cells, we used a bioinformatics analysis of the published transcriptome data in CD34+CD38low CML stem cells (dataset GSE11889).